Brian Zeno, MD
Pulmonary Disease · Columbus, OHNPI 1033149596
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,000 of the $5,782 with a category attached, or 69.2%. Intuitive Surgical accounts for 92.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $3,863 and has fallen 61.2% since, to $1,500 in 2025.
Across 15 payments — averaging $385.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Johnson & Johnson$124
- Boston Scientific$120
- Pulmonx Corporation$118
- AstraZeneca$57
Across 231 payments — averaging $12,931 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$770K
- Novartis$417K
- GSK$407K
- Hoffmann-la Roche Limited$338K
- Chiesi USA, Inc.$300K
- Mylan Specialty L.p.$277K
- plus $477K from 5 others
What the payments were for
- Travel & lodging$1,09119%
- Food & beverage$69112%
- Education$4,00069%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 10 | $5,363 |
| Johnson & Johnson | 1 | $124 |
| Boston Scientific | 1 | $120 |
| Pulmonx Corporation | 1 | $118 |
| AstraZeneca | 2 | $57 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,782 in reported general payments places this provider in the 70th percentile of 571 pulmonary disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Columbus
- Christian GhattasColumbus$286K
- Alberto ReveloColumbus$202K
- James FaganColumbus$179K
- Jeffrey HorowitzColumbus$31K
- Ehab HusseinColumbus$25K
- Joseph KhabbazaAkron$655K
- Robert BaughmanCincinnati$640K
- Kristin HighlandCleveland$551K
- Bruce CorserCincinnati$502K
- Jason StieneckerLima$397K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.